2-aryl thiazole derivatives as KCNQ modulators
US7273866B2 · kind B2 · utility
0Cited by
13References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2003 |
| Grant date | Sep 25, 2007 |
| Priority date | — |
| Expiry date | Aug 14, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 2-arylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders that are responsive to the opening of the KCNQ potassium channels, including pain and migraine
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.